Kura Oncology’s (KURA) Market Outperform Rating Reiterated at JMP Securities
JMP Securities reissued their market outperform rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research note published on Tuesday,Benzinga reports. The brokerage currently has a $28.00 price objective on the stock. KURA has been the subject of several other reports. UBS Group reduced their price target on Kura Oncology from $27.00 […]
JMP Securities reissued their market outperform rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research note published on Tuesday,Benzinga reports. The brokerage currently has a $28.00 price objective on the stock. KURA has been the subject of several other reports. UBS Group reduced their price target on Kura Oncology from $27.00 […]
